Resonantia Diagnostics Inc

Resonantia Diagnostics is developing a transformative ‘end-to-end’ diagnostic platform to address the burden of drug-resistant bacterial and fungal infections. In approximately 60 minutes, Resonantia’s platform tells clinicians what’s causing an infection and what antibiotic will stop the infection using antimicrobial susceptibility testing (AST).